Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Danggui Shaoyao San and Cuscuta Chinensis in Primary Dysmenorrhea
NCT06730282Terminated
- Sponsor
- Taichung Tzu Chi Hospital
- Start
- Feb 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Danggui Shaoyao San and semen cuscutae in primary dysmenorrhea (PD) (4 arms), sponsored by Taichung Tzu Chi Hospital. Primary endpoint: Change in Pain Intensity Measured by the Visual Analogue Scale at 8 weeks. Started Feb 2025; status: terminated.
02
Drugs
Danggui Shaoyao Sansemen cuscutae
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT06730282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06730282.